Devices and methods for molecular diagnostic testing
Inventors
Andreyev, Boris • Moravick, Keith E. • Ciopyk, Brian • Briones, Victor • Loney, Gregory • De La Zerda, Adam • Ching, Jesus • Chu, Steven • Swenson, David • Huang, Helen • Kelly, Colin
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Assignees
Visby MedicalVisby Medical develops rapid at-home molecular diagnostic tests powered by polymerase chain reaction (PCR) technology, focusing on accessible, private, and accurate screening for sexually transmitted infections (STIs). The company offers the first FDA-authorized over-the-counter at-home PCR test for women’s sexual health and is expanding its diagnostics platform to address other infectious diseases for point-of-care and home use. Its technology enables results in approximately 30 minutes via a secure mobile app, with integrated telehealth services for positive results. Visby Medical emphasizes user privacy, scalable manufacturing, and partnerships to broaden access to high-quality diagnostics.
Visby Medical develops rapid at-home molecular diagnostic tests powered by polymerase chain reaction (PCR) technology, focusing on accessible, private, and accurate screening for sexually transmitted infections (STIs). The company offers the first FDA-authorized over-the-counter at-home PCR test for women’s sexual health and is expanding its diagnostics platform to address other infectious diseases for point-of-care and home use. Its technology enables results in approximately 30 minutes via a secure mobile app, with integrated telehealth services for positive results. Visby Medical emphasizes user privacy, scalable manufacturing, and partnerships to broaden access to high-quality diagnostics.
Abstract
A hand-held molecular diagnostic test device includes a housing, an amplification (or PCR) module, and a detection module. The amplification module is configured to receive an input sample, and defines a reaction volume. The amplification module includes a heater such that the amplification module can perform a polymerase chain reaction (PCR) on the input sample. The detection module is configured to receive an output from the amplification module and a reagent formulated to produce a signal that indicates a presence of a target amplicon within the input sample. The amplification module and the detection module are integrated within the housing.
Core Innovation
The invention relates to a housing-based apparatus for molecular diagnostics that receives an input sample and includes a sample input module, an amplification module defining a reaction volume with a heater, and a detection module. A nonpathogenic solid positive control is included within the sample input module, where the positive control is rehydrated and mixed with the input sample when conveyed from the sample input volume. The amplification module amplifies a control nucleic acid within the positive control to produce a control amplicon while also amplifying a target nucleic acid within the input sample to produce a target amplicon.
The apparatus includes a reagent formulated to produce a first signal indicating the presence of the target amplicon and a second signal indicating the presence of the control amplicon. The detection module receives an output produced by the amplification module that includes both the target amplicon and the control amplicon, and the detection module contains a first detection surface and a second detection surface. The first detection surface interacts with the target amplicon and the second detection surface interacts with the control amplicon so that separate signals are produced from the respective detection surfaces.
The disclosed configurations describe a serpentine amplification flow path and heater-defined temperature zones. The detection module produces colorimetric, enzyme-linked detection signals on multiple probe-spotted surfaces, including probe-based target species and positive and negative controls, viewable through a window as non-fluorescent signals. The system is implemented as a point-of-care device with a disposable amplification format and a fluid-transfer workflow that supports mixing, fluid delivery, sequential reagent delivery, timed incubation, and signal generation.
Claims Coverage
The document includes two independent claims. Both are directed to a housing-based point-of-care molecular diagnostic apparatus that amplifies target and control nucleic acids and then produces separate signals on distinct detection surfaces. The claims collectively recite a nonpathogenic solid positive control that is rehydrated and mixed, an amplification module with a heater, a reagent producing signals for target and control amplicons, and a detection module with first and second detection surfaces.
Nonpathogenic solid positive control rehydrated and mixed with the input sample
A solid positive control within the sample input module is nonpathogenic to humans and is rehydrated and mixed with the input sample when the input sample is conveyed from the sample input volume.
Amplification module generating target and control amplicons
An amplification module coupled within the housing defines a reaction volume and includes a heater, and is configured to amplify a control nucleic acid within the positive control to produce a control amplicon along with amplification of a target nucleic acid within the input sample to produce a target amplicon.
Reagent formulated to produce first signal for target amplicon and second signal for control amplicon
A reagent stored within the housing or within a reagent module is formulated to produce a first signal indicating presence of the target amplicon and a second signal indicating presence of the control amplicon.
Detection module with separate first and second detection surfaces producing separate signals
A detection module coupled within the housing receives an output from the amplification module that includes the target amplicon and the control amplicon, and includes a first detection surface and a second detection surface configured to interact with the respective amplicons so that the first signal is produced from the first detection surface and the second signal is produced from the second detection surface.
Across the independent claims, the inventive concept is a housing-based apparatus that amplifies both a target nucleic acid and a control nucleic acid derived from a nonpathogenic solid positive control, then uses a reagent and a detection module with distinct detection surfaces to generate separate signals for the target amplicon and the control amplicon.
Stated Advantages
Produces a first signal indicating presence of the target amplicon and a second signal indicating presence of the control amplicon using separate detection surfaces.
Uses a nonpathogenic solid positive control within the sample input module that is rehydrated and mixed with the input sample.
Supports molecular diagnostics within a housing-based apparatus including an amplification module with a heater and an integrated detection module.
Documented Applications
Infectious disease panels.
Urine/swab STI panel.
Urinary tract infection panel.
Viral RNA workflow with RT prior to PCR.
Interested in licensing this patent?
